Amorphous powders for inhalation drug delivery

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Technologies
• Materials Science

Background:

• Amorphous powder formulations offer enhanced bioavailability for poorly soluble drugs and improved stability for biologics in inhalation drug delivery.
• Despite advantages, amorphous formulations typically exhibit poor physicochemical stability, limiting their application.
• Developing stable amorphous inhalable powders is crucial for effective respiratory therapies.

Purpose of the Study:

• To review the production methods for inhalable amorphous powders.
• To discuss active pharmaceutical ingredients and excipients used in these formulations.
• To highlight strategies for stabilizing inhalable amorphous particles.

Main Methods:

• Literature review of amorphous powder formulation production techniques for inhalation.
• Analysis of active pharmaceutical ingredients and excipients relevant to amorphous solid dispersions.
• Examination of particle stabilization approaches for amorphous inhalable powders.

Main Results:

• Various production methods exist for amorphous inhalable powders, each with specific advantages.
• Selection of appropriate active pharmaceutical ingredients and excipients is key to formulation success.
• Particle engineering and formulation strategies are critical for achieving long-term physicochemical stability.

Conclusions:

• Inhalable amorphous powders present significant opportunities for advanced respiratory drug delivery.
• Overcoming the inherent instability of amorphous forms is achievable through careful selection of manufacturing processes and excipients.
• Further research into stabilization techniques will expand the therapeutic potential of these formulations.